Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-2254

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-2254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for OXcarbazepine 600 mg film-coated tablets, quantity 30, repackaged by RemedyRepack Inc. The label includes the NDC number 70518-2254-00 and manufacturing details with storage instructions. The label clearly states RX only and provides a caution to keep medication out of children’s reach.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure diagram of oxcarbazepine showing the molecular framework with two benzene rings fused to a seven-membered ring containing a nitrogen atom and a ketone group, along with a CONH2 (carboxamide) substituent attached to the nitrogen.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A Kaplan-Meier survival curve comparing exit rates over time (days) on trial from Day 2 to Day 11, showing two treatment groups: Oxcarbazepine (solid line) and Placebo (dotted line). The graph includes a log-rank test p-value of 0.0001 indicating statistical comparison between groups.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A survival curve graph comparing seizure rates over time between treatment groups of Oxcarbazepine and Placebo. The x-axis shows days from first dose to first seizure, ranging from 0 to 140 days. The y-axis shows seizure rate from 0.0 to 1.0. The Oxcarbazepine group is represented by a solid line with generally lower seizure rates compared to the Placebo group, shown with a dotted line. The graph includes a log-rank test p-value of 0.046 indicating statistical comparison between groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A Kaplan-Meier survival curve chart showing exit rate over time in days for two treatment groups labeled HIGH (solid line) and LOW (dotted line). The chart includes a log-rank test with p-value=0.0001, indicating statistical comparison between the groups' exit rates over a period up to 130 days.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier curve comparing exit rates over time between two treatment groups labeled HIGH and LOW. The x-axis shows time to exit in days (0 to 130), and the y-axis shows exit rate (0.0 to 1.0). The LOW group curve rises quickly, nearing an exit rate of 1.0, while the HIGH group increases more gradually, leveling off around 0.4. A log-rank test p-value of 0.0001 is indicated, suggesting significant difference between groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.